Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: Results from the Norfolk Arthritis Register

Annals of the Rheumatic Diseases

Volumn 66, Issue 4, 2007, Pages 486-492

  Farragher, Tracey M ^a   Lunt, Mark ^a   Bunn, Diane K ^b   Silman, Alan J ^a   Symmons, Deborah P M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POLYARTHRITIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; REGISTER; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STRUCTURED INTERVIEW;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ARTHRITIS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DISABILITY EVALUATION; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 34147211087     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.056390     Document Type: Article

References (40)

1. Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
2. Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
4. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530- 42.
5. Pincus T, Callahan LF, Vaughn WK. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis. J Rheumatol 1987;14:240-51.
6. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34.
7. Callahan LF, Pincus T, Huston JW III, Brooks RH, Nance EP Jr, Kaye JJ, et al. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997;10:381-94.
8. Wiles N, Dunn G, Barrett E, Silman A, Symmons D. Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. J Clin Epidemiol 2000;53:988-96.
9. Pollard L, Choy EH, Scott DL. The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 2005;23:S43-52.
10. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
11. Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072-7.
12. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999;38:668-74.
13. Goodson NJ, Wiles NJ, Lunt M, Barrett M, Silman AJ, Symmons DPA, et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002;46:2010-19.
14. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
15. Goodson NJ, Silman AJ, Pattison DJ, Lunt M, Bunn D, Luben R, et al. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. Rheumatology 2004;43:731-6.
16. Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries RR, Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis 1990;49:980-2.
17. Boers M, Nurmohamed MT, Doelman CJ, Verhoeven AC, Voskuyl AE, Huizinga TW, et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:842-5.
18. Wollberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis, a retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
19. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in british patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9.
22. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003;1:20.
23. World Health Organisation. International classification of diseases, ninth revision. Geneva: World Health Organisation, 1977.
24. World Health Organisation International classification of diseases, tenth revision. Geneva: World Health Organization, 1994.
25. Symmons DPM, Hazes JM, Silman AJ. Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol 2003;30:902-4.
26. Harrison BJ, Symmons DPM, Barrett EM, Silman AJ. The performance of the 1987 ara classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 1998;25:2324-30.
27. Sokka T, Hakkinen A, Krishnan E, Hannonen P. Similar prediction of mortality by the Health Assessment Questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 2004;63:494-7.
28. Minuar NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ. Outcome After 40 years with Rheumatoid Arthritis: A Prospective Study of Function, Disease Activity, and Mortality. J Rheumatol 2004;31(Supp 69):3-8.
29. Callahan LF, Cordray DS, Wells G, Pincus T. Formal education and five-year mortality in rheumatoid arthritis: mediation by Helplessness Scale score. Arthritis Care Res 1996;9:463-72.
30. Soderlin MK, Nieminen P, Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 1998;25:1895-9.
31. Leigh JP, Fries JF. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 1991;18:1307-12.
32. Peltomaa R, Paimela L, Kautiainen H, Leirisalo-repo M. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 2002;61:889-94.
33. Chehata JC, Hassell AB, Clarke SA, Mattey DL, Jones MA, Jones P, et al. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology 2001;40:447- 52.
34. Yelin E, Trupin L, Wong B, Rush S. The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 2002;29:1851-7.
35. Harrison BJ, Symmons DP, Brennan P, Bankhead CR, Barrett EM, Scott DGI, et al. Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol 1996;23:1326-31.
36. Wiles NJ, Dunn G, Barrett EM, Harrison Bj, Silman Aj, Symmons DP. One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline. J Rheumatol 2000;27:2360-6.
37. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005;52:2293-9.
38. Coste J, Jougla E. Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol 1994;23:545-52.
39. Gabriel SE, Crowsen CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529-33.
40. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7.